Articles
Digitalizing drug recalls for improved patient safety
Now that serialization is the pharma supply chain’s established reality, it’s time to accelerate the return on the capital invested in compliance solutions.
The “what’s next?” question has been on the minds of many in the industry, including leading pharmaceutical...
Articles
Technology transfer for a Good management are keys for considerable experience in transferring aseptic processes and systems
There are many reasons for pharma and biotech companies for a technology transfer: Some need a back-up strategy for risk management to provide an adequate market supply for the patient.
For others, there may be a lack of appropriate resources/capacity...
Articles
Global Developments in Real-World Evidence
Real-world evidence (RWE) and real-world data (RWD) can ‘generate insights about a medicine’s effectiveness, safety and associated costs,1 and due to the emergence of value-based payments (VBP), the relevance and importance of RWE is being further emphasized across the...
Articles
Injecting New Blood into the Life Sciences Innovation Process
Innovation and collaboration are the lifeblood of the life sciences. Without them, both research and business come to a standstill.
Knowing this, how do pharmaceutical and biotechnology companies get the blood pumping, communicate their position to the marketplace as well...
Articles
Change and innovation in the pharma supply chain: more of the same in 2019?
2018 has seen some of the most fundamental changes to the pharmaceutical industry– driven by serialisation requirements in the US and EU, as there has been a seismic shift towards a more digitalised supply chain. The...
Articles
Transforming The Life Sciences Supply Chain Through Blockchain
Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments?
With many serialization and track & trace regulations in the compliance period, and others (e.g., EU FMD, US DSCSA) on...
Articles
The need of innovation in the injectable business – a CDMO perspective
The world of drug development and manufacturing is undergoing a change. Nowhere is this more evident than in the rapid increase in complex compounds such as biologics.
This change is further compounded with the erosion of the once commanding ‘blockbuster’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read